CDSCO UID IMP/IVD/2019/000089_f8d65a5810677fd689acd8e29b003635_3f3abf55ab0ba1126507c715d78118a5LIAISON IGF-1 Control
- UID
- IMP/IVD/2019/000089_f8d65a5810677fd689acd8e29b003635_3f3abf55ab0ba1126507c715d78118a5
- Device class
- Class B
- Brand name
- LIAISON® EASY System Liquid
- License holder
- Diasorin Healthcare India Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- The LIAISON® IGF-I controls (LIAISON® EASY System Liquid) are to be used in LIAISON® chemiluminescent immunoassays (LIAISON® EASY System Liquid) as a means of checking reliability of assay runs. The performance characteristics of LIAISON® IGF-I Control have not been established for any other assays or instrument platforms different from LIAISON® and LIAISON® XL
LIAISON IGF-1 Control is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000089_f8d65a5810677fd689acd8e29b003635_3f3abf55ab0ba1126507c715d78118a5. This device is marketed under the brand name LIAISON® EASY System Liquid. The license holder is Diasorin Healthcare India Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.